When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HLUYY - Lundbeck's Lu AG06466 flunks mid-stage study; shares down 4%
H Lundbeck A/S S/Adr
Appearing motivated to release all the bad news at once, H. Lundbeck A/S (OTCPK:HLUYY-4.0%) announces another failed clinical trial, this time a Phase 2a study evaluating Lu AG06466 in adults with a movement disorder called Tourette syndrome.
More news on: H. Lundbeck A/S, H. Lundbeck A/S, Healthcare stocks news, Stocks on the move,